Immediate Impact
1 from Science/Nature 62 standout
Citing Papers
Polymeric Nanoparticles for Drug Delivery
2024 Standout
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
Works of Clare Griffin being referenced
Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial
2010
Interferon alfa-2a versus combination therapy with interferon alfa-2a, interleukin-2, and fluorouracil in patients with untreated metastatic renal cell carcinoma (MRC RE04/EORTC GU 30012): an open-label randomised trial
2010
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Clare Griffin | 433 | 203 | 320 | 367 | 52 | 1.3k | |
| Yutao Gong | 257 | 87 | 59 | 96 | 34 | 1.1k | |
| M.R. Caballı́n | 228 | 130 | 30 | 625 | 93 | 1.7k | |
| Jerry L. Klein | 201 | 113 | 89 | 112 | 42 | 1.2k | |
| Mary Huang | 488 | 101 | 153 | 53 | 53 | 1.7k | |
| Marie Lundell | 387 | 289 | 162 | 120 | 49 | 1.6k | |
| C. Richter | 93 | 95 | 13 | 194 | 64 | 1.2k | |
| Paul Abel | 519 | 194 | 20 | 178 | 59 | 1.5k | |
| Oskar Hagberg | 157 | 301 | 30 | 40 | 65 | 1.2k | |
| Hermann Lisco | 129 | 62 | 44 | 111 | 31 | 1.1k | |
| C. A. Joslin | 246 | 225 | 189 | 176 | 52 | 1.3k |
All Works
Login with ORCID to disown or claim papers
Loading papers...